Xconomy National

Archives

by in

Entry	Author	Date	Location
George Scangos, the Boy From Working Class Boston, on His Road Back to Lead Biogen Idec	Luke Timmerman	08/31/11	Boston
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent	Luke Timmerman	07/18/11	National
Dendreon Faces Internet-Fueled Shareholder Uprising, Led by a Little Guy in Kansas	Luke Timmerman	04/01/11	Seattle
Biogen Idec Nabs Doug Williams as R&D Head, Steve Holtzman as BD Chief To Fill Out Management Team	Luke Timmerman	01/05/11	Boston
Biogen Idec Chief Aims to Make Firm More Like Biotech and Less Like Pharma with Restructuring Plan	Ryan McBride	11/04/10	Boston
5 Biotech Storylines to Watch in Boston	Ryan McBride	10/13/10	Boston
Motricity’s Ryan Wuerch on the Post-IPO Game Plan, International Expansion, and the New Wave of Mobile	Thea Chard	10/08/10	Seattle
Genzyme Boss Henri Termeer Not Ready To Sell to Sanofi, Ride Into the Sunset, Sources Say	Ryan McBride	09/22/10	Boston
Genzyme Agrees to Sell Genetics Unit to LabCorp for $925M	Ryan McBride	09/13/10	Boston
Susan Windham-Bannister on the State of the State’s $1B Life Sciences Initiative, Part II	Ryan McBride	08/18/10	Boston
Susan Windham-Bannister on the State of the State’s $1B Life Sciences Initiative, Part I	Ryan McBride	08/17/10	Boston
Xconomy Readers Set $20B Pricetag on Genzyme—Is That Too Rich for Sanofi-Aventis?	Ryan McBride	07/29/10	Boston
Genzyme Stock Surges 15 Percent on Sanofi Buyout Speculation	Luke Timmerman	07/23/10	Boston
New CEO George Scangos Says Biogen Idec’s R&D Has to Improve	Ryan McBride	07/01/10	Boston
Reports: Biogen Picks Exelixis Chief George Scangos as New CEO	Ryan McBride	06/30/10	Boston
Motricity Completes IPO, Settles For $50M	Luke Timmerman	06/18/10	Seattle
Curis Misses Mark in Cancer Drug Trial, Genzyme Re-Elects Full Board, GTC Cuts Jobs, & More Boston-Area Life Sciences News	Erin Kutz	06/18/10	Boston
Genzyme Annual Meeting Remarkably Mundane, Despite Rocky Year	Ryan McBride	06/16/10	Boston
Polaris Raises $234M for New Fund, BioScale Pins Down $25M, Clinical Data Nets $30M, & More Boston-Area Deals News	Erin Kutz	06/16/10	Boston
Genzyme Borrows $1B for Stock Buyback	Ryan McBride	06/15/10	Boston
Modumetal Closes Series B, TerraPower Pulls In $35M, Vertafore Bought for $1.4B, & More Seattle-Area Deals News	Gregory T. Huang	06/15/10	Seattle
Motricity, Riding the Mobile Software Wave, Primed for $85M IPO This Week	Luke Timmerman	06/14/10	Seattle
Biogen CEO Retires, Genzyme Board Nominates Amgen Vet and Strikes Deal with Icahn, Xconomy Spotlights Life Sciences XSITE Speakers, & More Boston-Area Life Sciences News	Erin Kutz	06/11/10	Boston
Genzyme Cuts Deal With Carl Icahn on Eve of Shareholder Vote	Ryan McBride	06/09/10	Boston
Biogen’s CEO Retires Tomorrow, COO to Follow	Ryan McBride	06/07/10	Boston
Genzyme Taps Amgen Vet for Board	Ryan McBride	06/07/10	Boston
Oxford’s Fambrough Leaves for Dicerna, Clinical Data Aims to Take on Big Pharma with Antidepressants, Genzyme’s Termeer Courts Shareholders, & More Boston-Area Life Sciences News	Erin Kutz	05/14/10	Boston
Genzyme in “Tough Spot” with Icahn Proxy Challenge—CEO Termeer Courting Key Shareholders	Ryan McBride	05/13/10	Boston
Icahn Blasts Genzyme Manufacturing, Glaxo Halts “Red Wine” Drug Trial, Ariad Gets $69M from Merck, & More Boston-Area Life Sciences News	Erin Kutz	05/07/10	Boston
$2B Stock Buyback for Genzyme	Erin Kutz	05/06/10	Boston
Page 1 of 6	next page »